Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
BACKGROUND: Some evidence suggests that proton pump inhibitors (PPIs) are an under-appreciated risk factor for hypomagnesemia. Whether hospitalization with hypomagnesemia is associated with use of PPIs is unknown. METHODS AND FINDINGS: We conducted a population-based case-control study of multiple h...
Main Authors: | Jonathan Zipursky, Erin M Macdonald, Simon Hollands, Tara Gomes, Muhammad M Mamdani, J Michael Paterson, Nina Lathia, David N Juurlink |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-09-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC4181956?pdf=render |
Similar Items
-
Proton pump inhibitors and hypomagnesemia monitoring
by: Lemon TI
Published: (2013-08-01) -
Is hypomagnesemia associated with using proton pump inhibitors?
by: Joo-Hark Yi, et al.
Published: (2016-06-01) -
Proton pump inhibitors and the risk of adverse cardiac events.
by: David N Juurlink, et al.
Published: (2013-01-01) -
Proton-pump inhibitor use amongst patients with severe hypomagnesemia
by: Sherry Seah, et al.
Published: (2023-01-01) -
Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
by: John Hughes, et al.
Published: (2018-01-01)